None listed
Conditions
Interventions
None listed
Sponsors
CENTRAL COUNCIL FOR RESEARCH IN AYURVEDIC SCIENCES Ministry of AYUSH, Government of India
Eligibility
Inclusion criteria
Inclusion criteria: 1.Apparently Healthy Adults of age group from 18 to 60 years of all genders 2.Apparently Healthy Adults with or without removable or fixed prostheses or fixed and removable orthodontic appliances will be included. 3.Poor orodental hygiene with Simplified Oral Hygiene Index (OHI-S)- 3 to 6
Exclusion criteria
Exclusion criteria: 1.Population with uncontrolled systemic comorbidities like DM, HTN, IHD from available reports & ongoing medication record 2.Population with significant orodental pathology 3.Oral carcinoma in situ. 4.Oral premalignant conditions like- Erythroplakia, leukoplakia, OSMF (Screened participants with cancerous, precancerous lesions will be referred to Tata Memorial Hospital for further evaluation and management) 5.Use of antibiotics and anti-inflammatory drugs in previous one month 6.History of mouth rinses, gels or chewing gums use, that contain antimicrobial agents in the preceding one month 7.Chronic users of tobacco products (for more than three years) in its various forms 8.Participants with a history of regular or recent inhalation of corticosteroids 9.Allergy to any ingredient used in the study 10.Oral pathology that is interfering with the conduction of Gandoosha procedure- like OA/RA of TM joint 11.Participants with already a habit of practicing Gandoosha with any liquid 12.Pregnant or lactating females 13.Participants with hampered cough reflex
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Salivary Microbiome Profiles (Day 0 and Day 21) 2. Simplified Oral Hygiene Index (OHI-S) (Day 0 and Day 21)Timepoint: Day 0 and Day 21 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Status of orodental health assessed on the basis of WHO Oral Health Assessment form- Adults 2. Change in existing orodental clinical signs and symptoms, if present (E.g.- tastelessness, halitosis, dental pain, sensitive tooth, mouth ulcers, gingival pain, bleeding etc.) 3. Safety profile assessed by incidence of AEs/ADRs 4. Treatment adherence will be assessed through the MARS-5 questionnaire.Timepoint: Day 0 and Day 21 | — |
Countries
India
Contacts
Public ContactDr R Govind Reddy
RRAP CENTRAL AYURVEDA RESEARCH INSTITUTE, Mumbai, CCRAS, MINISTRY OF AYUSH, GOVERNMENT OF INDIA
Outcome results
None listed